A pioneering study presented at ECTRIMS 2024 has identified critical biomarkers that can predict disability worsening...

A new study has revealed significant therapeutic inertia in the treatment of women with multiple sclerosis (MS),...

Recent developments in the understanding of MS pathogenesis have suggested new avenues for disease-modifying therapy; in...

This year’s Neurology Update Meeting will be highly relevant for specialists and generalists managing neurology illness...

Interferon seems to raise migraine risk in people with MS, while rituximab may lower it. A...

The American Headache Society recently issued a position statement update on the use of migraine prevention...

An overview of the latest insights, diagnostic criteria, and treatment approaches for migraines. Migraine is the...

A new treatment for Parkinson’s disease has recently been made available in Ireland...

Irish Neurological Association, Annual Meeting, Kilkenny Ormonde Hotel, 2-3 May 2024...

The Irish Neurological Association (INA) Business Meeting was held on 2 May during the Association’s Annual...

The treatment of Alzheimer’s disease is entering a new era with the recent emergence of a...

Plans are in development to set up an Irish-based service for people with multiple sclerosis (MS)...